News Archive

• 01.30.2026  |  In brief this week: Natera, Revvity, Becton Dickinson, Wellcome, CARB-X

  360DX | Global charitable organization Wellcome and the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced this week that they haverenewed their partnership.

  Full Story

• 01.29.2026  |  CARB-X receives $60 million from Wellcome to support early-stage antibiotic R&D

  CIDRAP | CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) said yesterday that it will receive $60 million in funding over the next two years from global charitable foundation Wellcome.

  Full Story